Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026
Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy
Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy
Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN
Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy Opportunity on September 29, 2025
Surface Metals Inc. Expands Land Holdings in Advance of Drilling Campaign at Cimarron Gold Project, Nevada
QIMC Intersects Major Fault Breccia System in DDH-26-03 at West Advocate and Reports Elevated Hydrogen 2.5 km from the Initial Discovery
